SAM
IONS icon

Solaris Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Solaris Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-675
Closed -$34K – 112
2017
Q4 		$34K Hold
675
– – 0.02% 182
2017
Q3 		$34K Hold
675
– – 0.02% 195
2017
Q2 		$34K Hold
675
– – 0.02% 200
2017
Q1 		$27K Hold
675
– – 0.02% 197
2016
Q4 		$32K Hold
675
– – 0.02% 189
2016
Q3 		$25K Hold
675
– – 0.02% 215
2016
Q2 		$16K Hold
675
– – 0.01% 176
2016
Q1 		$27K Buy
+675
New +$27.4K 0.02% 153

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Solaris Asset Management's IONS Position: Q1 2018 in Review

Solaris Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2018, closing a stake of 675 shares — an estimated $34K sold.

Solaris Asset Management first reported a position in IONS in Q1 2016 and held it in 8 quarters. The position peaked at $34K in Q4 2017. 325 funds tracked by Wall St. Rank hold IONS as of Q1 2018.

  • Solaris Asset Management reported no remaining Ionis Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Solaris Asset Management sold 675 Ionis Pharmaceuticals shares in Q1 2018, an estimated $34K.
  • Solaris Asset Management first reported a position in Ionis Pharmaceuticals in Q1 2016 and held it in 8 quarters.
  • Solaris Asset Management's Ionis Pharmaceuticals position peaked at $34K in Q4 2017.
  • 325 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2018.

Based on Solaris Asset Management's 13F filing for Q1 2018, filed 16 Apr 2018.